Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | NQO2 | P16083 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SOST | Q9BQB4 | 1/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | GSK3B | P49841 | 2/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ATR | Q13535 | 1/20 | 0.32 |
| ▸ | NQO1 | P15559 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | TARBP2 | Q15633 | 1/20 | 0.32 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29424759 | 1.00 | CYP19A1 (0.36) | CYP19A1NQO2KDM4ELMNASOST | |
| SCHEMBL29565868 | 1.00 | CYP19A1 (0.36) | CYP19A1NQO2KDM4ELMNASOST | |
| SCHEMBL30393960 | 0.99 | CYP19A1 (0.35) | CYP19A1NQO2KDM4ELMNASOST | |
| SCHEMBL25448348 | 0.95 | CYP19A1 (0.33) | CYP19A1NQO2KDM4ELMNASOST | |
| Acetic Acid SCHEMBL29538014 | 0.92 | TARBP2 (0.34) | CYP19A1NQO2KDM4ELMNANQO1 | |
| SCHEMBL18810594 | 0.91 | POLB (0.33) | CYP19A1NQO2KDM4ELMNAACHE | |
| SCHEMBL431846 | 0.90 | KDM4E (0.32) | CYP19A1NQO2KDM4ELMNASOST | |
| SCHEMBL1144617 | 0.88 | CYP19A1 (0.33) | CYP19A1NQO2 | |
| SCHEMBL18187041 | 0.88 | — | — | |
| SCHEMBL5896988 | 0.83 | NQO2 (0.38) | CYP19A1NQO2KDM4ELMNASOST |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3710422-B1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY AND DIASTEREOMERICALLY ENRICHED CYCLOBUTANE AMINES AND AMIDES | SYNGENTA CROP PROTECTION AG (CH) | 2026-01-07 | — | — | EP | claimed |
| CN-114773175-B | Preparation method of chiral tertiary alcohol benzo-fused bicyclo [ m.3.0] alkanone compound | 上海毕得医药科技股份有限公司 | 2023-11-03 | — | — | CN | claimed |
| CN-114773175-A | Preparation method of chiral tertiary alcohol benzo-fused bicyclo [ m.3.0] alkanone compound | 上海毕得医药科技股份有限公司 | 2022-07-22 | — | — | CN | claimed |
| US-11053188-B2 | Process for the preparation of enantiomerically and diastereomerically enriched cyclobutane amines and amides | SYNGENTA PARTICIPATIONS AG (CH) | 2021-07-06 | — | — | US | claimed |
| US-20200407311-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY AND DIASTEREOMERICALLY ENRICHED CYCLOBUTANE AMINES AND AMIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2020-12-31 | — | — | US | claimed |
| EP-2933246-B1 | VERSATILE AND FUNCTIONALISED INTERMEDIATES FOR THE SYNTHESIS OF VITAMIN D AND NOVEL VITAMIN D DERIVATIVES | ENDOTHERM GMBH (DE) | 2020-01-08 | — | — | EP | claimed |
| US-20150344421-A1 | Versatile and Functionalised Intermediates for the Synthesis of Vitamin D and Novel Vitamin D Derivatives | ENDOTHERM GMBH (DE) | 2015-12-03 | — | — | US | claimed |
| WO-2015178847-A1 | PROCESS FOR THE PREPARATION OF CHIRAL AMINES BY ASYMMETRIC HYDROGENATION OF PROCHIRAL OXIMES | SP PROCESS DEVELOPMENT AB (SE) | 2015-11-26 | — | — | WO | claimed |
| WO-2015178846-A1 | PROCESS FOR THE PREPARATION OF CHIRAL AMINES FROM PROCHIRAL KETONES | SP PROCESS DEVELOPMENT AB (SE) | 2015-11-26 | — | — | WO | claimed |
| EP-2933246-A1 | VERSATILE AND FUNCTIONALISED INTERMEDIATES FOR THE SYNTHESIS OF VITAMIN D AND NOVEL VITAMIN D DERIVATIVES | Endotherm GmbH (DE) | 2015-10-21 | — | — | EP | claimed |
| EP-2095875-B1 | Homogeneous asymmetric hydrogenation catalyst | TAKASAGO PERFUMERY CO LTD (JP) | 2014-10-01 | — | — | EP | claimed |
| EP-2392400-B1 | Homogeneous asymmetric hydrogenation method | TAKASAGO PERFUMERY CO LTD (JP) | 2014-05-07 | — | — | EP | claimed |
| US-7902110-B2 | Homogeneous asymmetric hydrogenation catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-03-08 | — | — | US | claimed |
| EP-1650207-B1 | Process for producing optically active 3-quinuclidinols | TAKASAGO PERFUMERY CO LTD (JP) | 2007-06-27 | — | — | EP | claimed |
| US-20260125363-A1 | PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMA (US) | 2026-05-07 | — | — | US | disclosed |
| EP-3792241-B1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | TAKASAGO PERFUMERY CO LTD (JP) | 2026-04-22 | — | — | EP | disclosed |
| US-12577251-B2 | Modulators of the sigma-2 receptor and their method of use | Temple University—Of the Commonwealth System of Higher Education (US) | 2026-03-17 | — | — | US | disclosed |
| US-20040063999-A1 | Process for the production of optically active amino alcohols | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2004-04-01 | — | — | US | disclosed |
| EP-1398310-A1 | Process for the production of optically active amino alcohols | Takasago International Corporation (JP) | 2004-03-17 | — | — | EP | disclosed |
| US-5872273-A | LIGANDS FOR FORMING HYDROGENATION CATALYST COMPLEXES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1999-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150344421-A1 | Versatile and Functionalised Intermediates for the Synthesis of Vitamin D and Novel Vitamin D Derivatives | VDR, CYP24A1, CYP2R1 | CYP19A1 97/4885NQO2 1071/4885KDM4E 3193/4885 |
| US-20260125363-A1 | PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | CFTR, SLC26A4, SLC26A3 | CYP19A1 4400/4885NQO2 1159/4885KDM4E 1638/4885 |
| US-20200407311-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY AND DIASTEREOMERICALLY ENRICHED CYCLOBUTANE AMINES AND AMIDES | TBCB, ADORA2B, ADRA2B | CYP19A1 566/4885NQO2 2322/4885KDM4E 1392/4885 |
| US-11053188-B2 | Process for the preparation of enantiomerically and diastereomerically enriched cyclobutane amines and amides | TBCB, ADORA2B, CCNB3 | CYP19A1 494/4885NQO2 2295/4885KDM4E 1866/4885 |
| US-12577251-B2 | Modulators of the sigma-2 receptor and their method of use | SIGMAR1, CHRNA6, NR3C2 | CYP19A1 1673/4885NQO2 2305/4885KDM4E 3458/4885 |
| US-20040063999-A1 | Process for the production of optically active amino alcohols | ADH1C, ADH1A, ADH5 | CYP19A1 1901/4885NQO2 1549/4885KDM4E 1324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.